Research
Explore MIND Foundation’s research initiatives, including clinical trials, surveys, and partner studies in psychedelic science. The page summarizes ongoing, completed, and featured projects that involve data collection and evidence-based research.
Provider
Details
Enrollment
Course Overview
The Research page presents scientific studies and surveys affiliated with or supported by the MIND Foundation. It includes clinical trials, acceptance research, partner studies, and survey-based projects related to psychedelic-assisted therapies and mental health care. Featured studies on the page include the DiMension phase 3 clinical trial, the completed EPIsoDE phase 2b trial, the Acceptance Study on stakeholder attitudes, and partner studies at OVID Clinic Berlin. The page also highlights ongoing, past, and featured survey studies from MIND and its global partners. This content is intended for readers interested in psychedelic research, study participation, and the clinical and societal implementation of psychedelic therapies. It provides a structured overview of the Foundation’s research activity rather than a formal training course.
Who is this for?
People interested in psychedelic research, clinical trials, survey studies, and the implementation of psychedelic therapies in mental health care.
About the Provider
European nonprofit research and implementation organization that organizes the INSIGHT Conference and allied public/professional events.
View MIND Foundation profileCourse Details
- PricePrice on request
- Lifecycle statusDiscontinued
- SkillsHarm ReductionIntegrationPsychotherapyPsilocybin TherapyMDMA-Assisted TherapyMicrodosingEthicsUnderstanding psychedelic research initiativesReviewing clinical trial summariesInterpreting survey-based researchLearning about psychedelic-assisted therapy studiesFollowing evidence-based mental health researchInterpreting clinical trial summariesReviewing survey-based research
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Add Spravato® to Your Practice with Our 8-Phases Implementation Roadmap
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Advanced Training
By Therapsil
Focused short-form trainings in psychedelic safety, harm reduction, and clinical skill. One listed topic is Psychedelic First Aid, presented in collaboration with Neuma Centre.